Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
770.000 KRW | -1,28% | -1,41% | +1,32% |
Attività
Numero di dipendenti: 4 284
Vendite per attività
KRW in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Contract Development and Manufacturing Organization
72,4
%
| 2 337 523 | 77,9 % | 2 674 291 | 72,4 % | +14,41% |
Biopharmaceutical Development and Commercialization
27,6
%
| 663 772 | 22,1 % | 1 020 298 | 27,6 % | +53,71% |
Vendite per regione
KRW in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe
63,7
%
| 1 785 875 | 59,5 % | 2 353 845 | 63,7 % | +31,80% |
Americas
26,3
%
| 853 984 | 28,5 % | 971 055 | 26,3 % | +13,71% |
Other
6,9
%
| 206 690 | 6,9 % | 255 120 | 6,9 % | +23,43% |
South Korea
3,1
%
| 154 746 | 5,2 % | 114 569 | 3,1 % | -25,96% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Chongbo Rim
CEO | Chief Executive Officer | 62 | 01/01/18 |
Doyoung Heo
DFI | Director of Finance/CFO | - | - |
Tae-Han Kim
CHM | Chairman | 66 | 21/04/11 |
Yong-Ho An
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Hyung-Woo Moon
CMP | Compliance Officer | 54 | 01/01/17 |
Dong-Joong Kim
BRD | Director/Board Member | 59 | - |
James Choi
IRO | Public Communications Contact | 57 | 01/01/14 |
Sojeong Lee
LAW | General Counsel | - | 23/08/23 |
Connie Kim
PRN | Corporate Officer/Principal | - | 01/01/21 |
Park Yong
HRO | Human Resources Officer | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chang-Woo Lee
BRD | Director/Board Member | 70 | - |
Tae-Han Kim
CHM | Chairman | 66 | 21/04/11 |
Seok-Woo Jung
BRD | Director/Board Member | 62 | - |
Jae-Wan Park
BRD | Director/Board Member | 69 | - |
Dong-Joong Kim
BRD | Director/Board Member | 59 | - |
Soon-Jo Kwon
BRD | Director/Board Member | 59 | - |
Geun-Nyeong Heo
BRD | Director/Board Member | 68 | 22/03/19 |
John Chongbo Rim
CEO | Chief Executive Officer | 62 | 01/01/18 |
Eunice Kim
BRD | Director/Board Member | 65 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 71 174 000 | 17 974 713 ( 25,25 %) | 0 | 25,25 % |
Coordinate società
SAMSUNG BIOLOGICS Co., Ltd.
300 Songdo Bio Way Yeonsu-gu
21987, Inchon
+
http://www.samsungbiologics.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+1,32% | 39,82 Mrd | |
-4,66% | 86,13 Mrd | |
-19,27% | 30,42 Mrd | |
+57,86% | 25,23 Mrd | |
-16,09% | 15,35 Mrd | |
-9,14% | 11,95 Mrd | |
-17,69% | 11,6 Mrd | |
-43,00% | 11,51 Mrd | |
+5,24% | 8,71 Mrd | |
-8,42% | 8,12 Mrd |
- Borsa valori
- Azioni
- Azione A207940
- Società Samsung Biologics Co.,Ltd.